Patents
Patents for C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups (9,964)
05/2010
05/25/2010US7723529 2-butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-5-[(3-(nitrooxy) propyl)carbonyloxy]methyl-1H-imidazole
05/25/2010US7723362 for controlling acarina
05/25/2010US7723344 Dipeptidyl peptidase inhibitors
05/25/2010CA2248303C Perfluorinated amide salts and their uses as ionic conducting materials
05/20/2010US20100125075 Antibacterial Agents
05/19/2010CN101709056A 2-[5-(2-oxyphenyl)-1,3,4-thiadiazole-2-thioether]-1-acetophenone compound
05/18/2010US7718678 diamino-substituted 1,2,5-oxadiazoles for treatment of cancer, gingivitis, antiatherosclerosis, as viricide, aniinflammatory agent, antiogenesis inhibitor and analgesic
05/18/2010US7718652 Substituted benzothiadiazinedioxide derivatives and methods of their use
05/14/2010WO2009134616A8 Novel inhibitors of hepatitis c virus replication
05/13/2010US20100120876 Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (glp-1) compound or a melanocortin-4 receptor (mc4) agonist peptide
05/13/2010US20100120874 Heterocyclic gamma secretase modulators
05/13/2010US20100120753 Anti-Infective Agents
05/13/2010US20100119972 Coating composition
05/13/2010US20100119481 5,6-dihydro-1h-pyridin-2-one compounds
05/12/2010EP2183233A1 Dithiazolidine and thiazolidine derivatives as anticancer agents
05/12/2010CN101704800A Azacrown ether containing sulfur compound, preparation and application thereof
05/12/2010CN101704797A compounds effecting glucokinase
05/12/2010CN101092405B Derivative of new benzothiadiazines, preparation method and usage
05/11/2010US7714004 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
05/11/2010US7713963 Acylated indanyl amines and their use as pharmaceuticals
05/11/2010US7713961 Substituted 1,2-ethylenediamines, methods for preparing them and uses thereof
05/11/2010CA2248244C Heterocyclic aromatic anion salts, and their uses as ionic conducting materials
05/06/2010WO2010050779A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
05/06/2010US20100113276 Use of n2-phenylamidines as herbicides
05/05/2010CN1871219B Hexylcarboxanilide
05/04/2010US7709478 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents
04/2010
04/29/2010WO2010048207A2 Aryl gpr120 receptor agonists and uses thereof
04/29/2010US20100105553 Thiadiazolyl oxyphenyl amidines and the use thereof as a fungicide
04/29/2010CA2740366A1 Aryl gpr120 receptor agonists and uses thereof
04/28/2010EP2179995A1 Method for production of purified ammonium salt of fluorinated bis-sulfonylimide
04/28/2010EP1590321B1 Aryl alkyl carbamate derivatives production and use thereof in therapy
04/28/2010CN101698666A 2-amino-1,3,4-thiadiazolethioacetamido aromatic hydrocarbon derivatives, method for preparing same and use of same
04/22/2010WO2010045303A2 Pyrrolidine, piperidine and piperazine derivatives and methods of use thereof
04/22/2010WO2010044054A1 Phenethylamide derivatives and their heterocyclic analogues
04/22/2010WO2010043377A1 New 2-amidothiadiazole derivatives
04/22/2010WO2010014666A3 Processes and intermediates for making sweet taste enhancers
04/22/2010CA2740614A1 New 2-amidothiadiazole derivatives
04/22/2010CA2739490A1 Pyrrolidine, piperidine and piperazine derivatives and methods of use thereof
04/22/2010CA2739344A1 Phenethylamide derivatives and their heterocyclic analogues
04/21/2010EP2177521A1 New 2-Amidothiadiazole Derivatives
04/21/2010EP2176260A1 Pyrazolo[1,5-a]pyridines and their use in cancer therapy
04/20/2010US7700636 Protein kinase inhibitors; antiproliferative agents; anticancer agents;antiinflammatory agents; metabolism disorders; antidiabetic agents
04/20/2010US7700634 (Indol-3-yl) heterocycle derivatives as agonists of the cannabinoid CB1 receptor
04/20/2010US7700633 5-(3,6-Dihydroxynaphthalen-2-yl)-1,1-dioxo-1,2,5-thiadiazolidin-3-one; inhibitors of protein tyrosine phosphatases; in combination with an anti-diabetic agents, a hypolipidemic agent, an anti-obesity agent or an anti-hypertensive agent
04/20/2010CA2494067C Hetero biaryl derivatives as matrix metalloproteinase inhibitors
04/20/2010CA2393159C Methods of treating tumors
04/15/2010WO2010042652A2 Heteroalkyl biphenyl antagonists of prostaglandin d2 receptors
04/15/2010WO2010042030A1 Aspartyl protease inhibitors
04/15/2010US20100094021 Novel method of preparation of 5-chloro-3-imidazol-1-yl-[1,2,4]thiadiazole and (3-imidazol-1-yl-[1,2,4]thiadiazol-5yl)-dialkyl-amines
04/14/2010EP1477482B1 Novel phenylalanine derivative
04/08/2010US20100087479 Compositions Useful as Inhibitors of Voltage-Gated Sodium Channels
04/08/2010US20100087442 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
04/07/2010CN101691362A Method for preparing N-phenyl-N-(1,2,3-thiadiazole) urea
04/06/2010US7691856 Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine receptor ligands
04/06/2010CA2464846C Dibenzylamine compounds and pharmaceutical use thereof
04/06/2010CA2252536C Ethylene derivatives and pesticides containing said derivatives
04/01/2010WO2009156098A3 Thiadiazolyloxyphenylamidines and use thereof as fungicides
04/01/2010WO2008139845A8 Novel amide derivative
04/01/2010US20100081693 Thiadiazole compound and use thereof
03/2010
03/31/2010EP2167504A2 Thiadiazole modulators of pkb
03/31/2010EP2166856A1 Chemical compounds
03/31/2010CN101687828A Thiadiazole derivatives as antidiabetic agents
03/30/2010US7687625 Antidiabetic agents; obesity; controlling appetite
03/30/2010CA2418084C Substituted and unsubstituted benzooxathiazoles and compounds derived therefrom
03/25/2010WO2010033824A1 Sulfonamide derivatives as inhibitors of ion channels
03/25/2010US20100075953 Substituted piperazines, (1,4) diazepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
03/25/2010CA2737199A1 Novel compounds as cannabinoid receptor ligands
03/24/2010CN101679313A Axl kinase inhibitors used in cancer or excess proliferative disease
03/23/2010US7683181 Cyclic N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, pharmaceutical compositions and methods for the therapeutic use thereof
03/23/2010CA2418972C Method for the production of a particle-containing preparation of tetrahydro-3,5-dimethyl-1,3,5-thiadiazin-2-thione
03/18/2010WO2010029048A1 1, 2, 5-thiadiazole derivatives useful as immune potentiators
03/18/2010WO2009134616A3 Novel inhibitors of hepatitis c virus replication
03/18/2010US20100069453 Certain Chemical Entities, Compositions, and Methods
03/18/2010US20100069349 Novel compounds as cannabinoid receptor ligands
03/16/2010US7678831 2-{2-[3-(4-chlorophenyl)acryloyl]-4-methylphenoxy}-4-phenylbutanoic acid; Peroxisome Proliferator Activated Receptors (PPAR); diabetes, dyslipidemia and/or atherosclerosis
03/16/2010US7678789 [1,2,4]-dithiazoli(di)ne derivatives, inducers of gluthathione-S-transferase and NADPH quinone oxido-reductase, for prophylaxis and treatment of adverse conditions associated with cytotoxicity in general and apoptosis in particular
03/11/2010WO2009156074A3 Thiadiazolyloxyphenylamidines and use thereof as fungicides
03/11/2010US20100063109 Thiadiazolidinone derivatives
03/11/2010US20100063013 Cathepsin cysteine protease inhibitors
03/09/2010US7674886 Chelation compounds, radionuclides
03/09/2010US7674809 Anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production
03/04/2010US20100056777 Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the c-ring
03/04/2010US20100056507 Phenyl derivatives and their use as a medicament
03/03/2010CN101663285A Thiadiazolyl oxyphenyl amidines and the use thereof as a fungicide
03/03/2010CN101659643A Crystalline form of hydrochlorothiazide and application thereof
03/02/2010US7671092 Paclitaxel enhancer compounds
03/02/2010US7670991 Substituted benzoylcyclohexenones and their use as herbicidal agents
02/2010
02/25/2010US20100048893 Substituted arylalkanoic acid derivatives and use thereof
02/25/2010US20100048542 Methods and compositions for treating primary and secondary tumors of the central nervous system (cns)
02/25/2010US20100048534 Crystalline lestaurtinib hydrates and crystalline lestaurtinib hemihydrate hemiacetonitrileate and crystalline lestaurtinib hemihydrate hemitetrahydrofuranate
02/25/2010US20100048533 Lestaurtinib crystalline form 1, crystalline lestaurimib anhydrate and amorphous lestaurimib
02/25/2010CA2730478A1 Prodrugs of methyl hydrogen fumarate
02/24/2010EP2155704A1 Thiadiazole derivatives as antidiabetic agents
02/23/2010US7666895 adduct comprising a molecule binding with a kinase; antiinflammatory agents; modulating activation state of p38 kinase protein; switch control ligands to induce or restrict conformation
02/23/2010US7666885 Enzyme inhibitors
02/18/2010WO2010019547A1 Imine derivatives as cannabinoid receptor ligands
02/18/2010US20100041721 Selective androgen receptor modulators
02/18/2010US20100041720 Novel compounds as cannabinoid receptor ligands
02/18/2010US20100041719 Mitotic kinesin inhibitors and methods of use thereof
02/18/2010CA2731102A1 Imine derivatives as cannabinoid receptor ligands
1 ... 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 ... 100